Filing Details
- Accession Number:
- 0000791908-13-000023
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-11-01 17:33:24
- Reporting Period:
- 2013-10-18
- Filing Date:
- 2013-11-01
- Accepted Time:
- 2013-11-01 17:33:24
- Original Submission Date:
- 2013-10-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 791908 | Xoma Corp | XOMA | Pharmaceutical Preparations (2834) | 942756657 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1210905 | D Paul Rubin | C/O Xoma Corporation 2910 Seventh Street Berkeley CA 94710 | Sr. Vp Clinical Dev. & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2013-10-18 | 5,254 | $4.71 | 3,534 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was made pursuant to Rule 10b5-1 trading plan adopted by the reporting person on 3/20/2013.
- Due to an error in the information that was provided to the reporting person by the issuer, the original Form 4 that was filed on October 21, 2013 neglected to report a sale of 5,254 shares of Common Stock on October 18, 2013. This Form 4 amends the original Form 4 by reporting that sale and by adjusting accordingly the shares reported as beneficially owned in Table I, Column 5.
- This transaction was executed in multiple trades ranging at prices from $4.65 to $4.81.The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
